CAROLINE FANOUS: Open Payments
NPI 1497581839 · CARROLLTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $65 |
| Novo Nordisk Inc | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Amgen Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CONFIRM RX, OTEZLA, QULIPTA, Veozah, AIRSUPRA, TZIELD, FARXIGA, FREESTYLE LIBRE.
Industry payments across TX — which companies pay providers there.
